Schedule 13D ownership disclosure

LUMOS PHARMA INC

Security class unavailable · CUSIP: 55028X109

Event date: 2020-03-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-20-000151
Form type
SC 13D
Filer
LUMOS PHARMA, INC.
CIK
CIK 1126234
Filed
Apr 01, 2020
Reporting period
Mar 18, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub